Tag: VIVA 2026
STORM-PE shows “significant correlation” between wearable-captured activity and walk test
A subset analysis of the landmark STORM-PE randomised controlled trial (RCT) demonstrated a significant correlation between real-world, daily step-based activity as captured on a consumer wearable...
Sirolimus-coated balloon angioplasty associated with lower one-year TLR rate in SirPAD...
Among patients with femoropopliteal artery disease and no tissue loss, angioplasty with the MagicTouch PTA sirolimus-coated balloon (Concept Medical) was associated with a lower...
CX co-chair receives VIVA 2026 LIVE Award
Charing Cross (CX) Symposium co-chair Andrew Holden (Auckland City Hospital, Auckland, New Zealand) received the VIVA Foundation's 2026 LIVE Award yesterday morning.
The prestigious accolade...
Sirolimus-eluting balloon achieves patency results in line with best-in-class paclitaxel devices,...
The Selution sustained limus release (SLR) Sustane drug-eluting balloon (DEB; MedAlliance/Cordis) has achieved patency results (90.3%) in line with best-in-class paclitaxel devices and the...
